ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,164.17
0.04%
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs Yen
157.846
0.01%
Brent Oil
84.665
-0.14%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Serologicals (MM) (SERO)

  7. Serologicals (MM) (SERO) ニュース

SERO

Serologicals (SERO)

Serologicals (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SERO
日付受信時刻ニュースソース見出しコード企業名
2006/07/1300 : 21Business WireSerologicals Announces Stockholder Approval of MergerNASDAQ:SEROSerologicals (MM)
2006/07/0622 : 00Business WireCelliance Enters Agreement with Novozymes A/S to Develop Animal-Free Recombinant Human AlbuminNASDAQ:SEROSerologicals (MM)
2006/06/2200 : 01Business WireSerologicals' Upstate Group Announces Winner of 2006 Young Cell Signaller Award; Rashu Bhargava Seth Receives Award at the ThirNASDAQ:SEROSerologicals (MM)
2006/05/1721 : 00Business WireSerologicals' Upstate Group Announces Five Finalists for the 2006 Young Cell Signaller Award; Winner to be chosen June 13, 2006NASDAQ:SEROSerologicals (MM)
2006/05/0304 : 02Business WireSerologicals Corporation Announces Completion of Acquisition of LINCONASDAQ:SEROSerologicals (MM)
2006/04/2619 : 00Business WireSerologicals Corporation Reports First Quarter Results; First Quarter Revenue Exceeds Expectations and Pro Forma Net Income upNASDAQ:SEROSerologicals (MM)
2006/04/2123 : 18Business WireChemicon International and Australian Stem Cell Centre Announce Exclusive Agreement to Commercialize Stem Cell ProductsNASDAQ:SEROSerologicals (MM)
2006/04/1722 : 00Business WireSerologicals Corporation Schedules First Quarter Earnings Release and Conference CallNASDAQ:SEROSerologicals (MM)
2006/04/1222 : 00PR Newswire (US)Stem Cell Signaling Measured for the 1st TimeNASDAQ:SEROSerologicals (MM)
2006/04/0100 : 23Business WireSerologicals Corporation Announces Completion of Acquisition of Cytomyx Ltd.NASDAQ:SEROSerologicals (MM)
2006/03/2408 : 34Business WireSerologicals Corporation Agrees to Acquire LINCO; Solidifies Serologicals as a Leader in Multiplexing MarketplaceNASDAQ:SEROSerologicals (MM)
2006/03/1623 : 00Business WireSerologicals Corporation Announces Expanded Multi-Year Distribution Agreement with Novo Nordisk; Celliance is Exclusive DistribNASDAQ:SEROSerologicals (MM)
2006/03/1423 : 00Business WireSerologicals Corporation Agrees to Acquire Cytomyx Ltd.; Expands Drug Discovery Screening PortfolioNASDAQ:SEROSerologicals (MM)
2006/03/0100 : 00Business WireChemicon International and Stem Cell Sciences Announce Launch of ESGRO Complete(TM) Product LineNASDAQ:SEROSerologicals (MM)
2006/02/2306 : 05Business WireSerologicals Corporation Reports Fourth Quarter and Full Year 2005 Results; Fourth Quarter Revenue up 26.0% and Pro Forma Net InNASDAQ:SEROSerologicals (MM)
2006/02/0823 : 15Business WireSerologicals Corporation Schedules Fourth Quarter Earnings Release and Conference CallNASDAQ:SEROSerologicals (MM)
2006/02/0802 : 06Business WireChemicon International and Cellumen Announce an R & D Agreement to Commercialize a Systems Cell Biology Approach to CytotoxicityNASDAQ:SEROSerologicals (MM)
2006/01/1723 : 35PR Newswire (US)SeraCare Closes Previously Announced Purchase of Celliance Milford AssetsNASDAQ:SEROSerologicals (MM)
2006/01/1100 : 30Business WireChemicon International and MorphoSys Enter into Worldwide Licensing Agreement for Research AntibodiesNASDAQ:SEROSerologicals (MM)
2006/01/0701 : 14Business WireSerologicals Corporation Announces Plant Rationalization ActionsNASDAQ:SEROSerologicals (MM)
2006/01/0400 : 00Business WireSerologicals Corporation to Present at 24th Annual JPMorgan Healthcare ConferenceNASDAQ:SEROSerologicals (MM)
2005/11/2921 : 00PR Newswire (US)SeraCare Announces Acquisition of Serologicals' Celliance Subsidiary AssetsNASDAQ:SEROSerologicals (MM)
2005/11/1504 : 30Business WireSerologicals Corporation President & CEO David A. Dodd to Speak at J. Mack Robinson College of Business at Georgia State UniversNASDAQ:SEROSerologicals (MM)
2005/11/1023 : 14Business WireSerologicals Corporation to Present at 2005 First Analysis Investment ConferenceNASDAQ:SEROSerologicals (MM)
2005/11/0901 : 45Business WireStem Cell Experts Engage at 2nd Annual Christopher Reeve Hot Topics in Stem Cell Biology Satellite SymposiumNASDAQ:SEROSerologicals (MM)
2005/10/2805 : 01Business WireSerologicals Corporation Reports Third Quarter Results; Revenues Increase 45% for the Quarter and 48% for First Nine MonthsNASDAQ:SEROSerologicals (MM)
2005/10/2622 : 00Business WireSerologicals Corporation to Present at JPMorgan Small Cap ConferenceNASDAQ:SEROSerologicals (MM)
2005/10/1803 : 46Business WireSerologicals Corporation Third Quarter 2005 Earnings Conference CallNASDAQ:SEROSerologicals (MM)
2005/10/1323 : 00Business WireSerologicals Corporation Announces UCOE PatentNASDAQ:SEROSerologicals (MM)
2005/10/0619 : 00Business WireChemicon Announces Agreement with Stem Cell Sciences for Exclusive Manufacturing and Marketing of Novel, Serum-free, Embryonic SNASDAQ:SEROSerologicals (MM)
 Showing the most relevant articles for your search:NASDAQ:SERO

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
CCOM
US500
US 500
NYSE
NKE
Nike
SPI
SP500
S&P 500
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有